X Chevalier

Summary

Country: France

Publications

  1. ncbi request reprint [Targeted anti-cytokine therapies for osteoarthritis]
    Xavier Chevalier
    Rhumatologie, Hopital Henri Mondor, 51 avenue du Mal de Lattre de Tassigny, 94101 Créteil
    Bull Acad Natl Med 190:1411-20; discussion 1420, 1475-7. 2006
  2. doi request reprint Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study
    X Chevalier
    Department of Rheumatology, Hospital Henri Mondor, University Paris XII, Creteil, France
    Arthritis Rheum 61:344-52. 2009
  3. ncbi request reprint Methodology for the assessment of treatments in hand osteoarthritis
    X Chevalier
    Department of Rheumatology, H pital Henri Mondor, France
    Osteoarthritis Cartilage 8:S70-2. 2000
  4. ncbi request reprint Safety study of intraarticular injection of interleukin 1 receptor antagonist in patients with painful knee osteoarthritis: a multicenter study
    Xavier Chevalier
    Department of Rheumatology, Hospital Henri Mondor, University Paris XII, Paris, France
    J Rheumatol 32:1317-23. 2005
  5. ncbi request reprint Questionnaire survey of management and prescription of general practitioners in knee osteoarthritis: a comparison with 2000 EULAR recommendations
    X Chevalier
    Department of Rheumatology, Hopital Henri Mondor, Creteil, France
    Clin Exp Rheumatol 22:205-12. 2004
  6. ncbi request reprint [Arthritis]
    Xavier Chevalier
    Service de rhumatologie Centre hospitalier Henri Mondor 94010 Créteil
    Rev Prat 53:665-73; quiz 673-4. 2003
  7. ncbi request reprint Tissue inhibitor of metalloprotease-1 (TIMP-1) serum level may predict progression of hip osteoarthritis
    X Chevalier
    Department of Rheumatology, Hopital Henri Mondor, Universite de Paris XII, Creteil, France
    Osteoarthritis Cartilage 9:300-7. 2001
  8. pmc Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial
    X Chevalier
    Department of Rheumatology, Henri Mondor Hospital, University Paris XII, Bd de Lattre de Tassigny, 94010 Creteil, France
    Ann Rheum Dis 69:113-9. 2010
  9. doi request reprint Prospective, multi-centre, randomised evaluation of the safety and efficacy of five dosing regimens of viscosupplementation with hylan G-F 20 in patients with symptomatic tibio-femoral osteoarthritis: a pilot study
    T Conrozier
    Department of Rheumatology, Centre Hospitalier Lyon Sud, Pierre Benite, France
    Arch Orthop Trauma Surg 129:417-23. 2009
  10. pmc Immunohistological study of entheses in spondyloarthropathies: comparison in rheumatoid arthritis and osteoarthritis
    L Laloux
    Department of Rheumatology, , , , France
    Ann Rheum Dis 60:316-21. 2001

Collaborators

Detail Information

Publications36

  1. ncbi request reprint [Targeted anti-cytokine therapies for osteoarthritis]
    Xavier Chevalier
    Rhumatologie, Hopital Henri Mondor, 51 avenue du Mal de Lattre de Tassigny, 94101 Créteil
    Bull Acad Natl Med 190:1411-20; discussion 1420, 1475-7. 2006
    ..Anti-TNF alpha therapy has also been tested in isolated cases of digital and knee osteoarthritis. Cytokine targeting in osteoarthritis is thus an appealing approach but one that needs to be validated in terms of the risk-benefit ratio...
  2. doi request reprint Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study
    X Chevalier
    Department of Rheumatology, Hospital Henri Mondor, University Paris XII, Creteil, France
    Arthritis Rheum 61:344-52. 2009
    ..To evaluate the clinical response, safety, and tolerability of a single intraarticular injection of anakinra in patients with symptomatic osteoarthritis (OA) of the knee...
  3. ncbi request reprint Methodology for the assessment of treatments in hand osteoarthritis
    X Chevalier
    Department of Rheumatology, H pital Henri Mondor, France
    Osteoarthritis Cartilage 8:S70-2. 2000
    ..To perform a review of methods in clinical trials of hand OA and outline a set of guidelines...
  4. ncbi request reprint Safety study of intraarticular injection of interleukin 1 receptor antagonist in patients with painful knee osteoarthritis: a multicenter study
    Xavier Chevalier
    Department of Rheumatology, Hospital Henri Mondor, University Paris XII, Paris, France
    J Rheumatol 32:1317-23. 2005
    ..In animal models of OA, IL-1 blockade by IL-1 receptor antagonist (IL-1Ra) can slow the progression of disease. We examined the safety of intraarticular (IA) injections of recombinant human IL-1Ra in patients with knee OA...
  5. ncbi request reprint Questionnaire survey of management and prescription of general practitioners in knee osteoarthritis: a comparison with 2000 EULAR recommendations
    X Chevalier
    Department of Rheumatology, Hopital Henri Mondor, Creteil, France
    Clin Exp Rheumatol 22:205-12. 2004
    ..Results of this questionnaire were compared with the 2000 EULAR recommendations on the treatment of knee OA...
  6. ncbi request reprint [Arthritis]
    Xavier Chevalier
    Service de rhumatologie Centre hospitalier Henri Mondor 94010 Créteil
    Rev Prat 53:665-73; quiz 673-4. 2003
  7. ncbi request reprint Tissue inhibitor of metalloprotease-1 (TIMP-1) serum level may predict progression of hip osteoarthritis
    X Chevalier
    Department of Rheumatology, Hopital Henri Mondor, Universite de Paris XII, Creteil, France
    Osteoarthritis Cartilage 9:300-7. 2001
    ..To determine the predictive value of serum levels of TIMP-1 and hyaluronic acid in a 1 year prospective study in hip osteoarthritis (OA)...
  8. pmc Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial
    X Chevalier
    Department of Rheumatology, Henri Mondor Hospital, University Paris XII, Bd de Lattre de Tassigny, 94010 Creteil, France
    Ann Rheum Dis 69:113-9. 2010
    ..The primary objective was to compare a single, 6 ml, intra-articular injection of hylan G-F 20 with placebo in patients with symptomatic knee osteoarthritis. The safety of a repeat injection of hylan G-F 20 was also assessed...
  9. doi request reprint Prospective, multi-centre, randomised evaluation of the safety and efficacy of five dosing regimens of viscosupplementation with hylan G-F 20 in patients with symptomatic tibio-femoral osteoarthritis: a pilot study
    T Conrozier
    Department of Rheumatology, Centre Hospitalier Lyon Sud, Pierre Benite, France
    Arch Orthop Trauma Surg 129:417-23. 2009
    ..The aim of this study was to assess different dosing regimens of hylan G-F 20, a high molecular-weight cross-linked derivative of HA, in the treatment of pain due to knee OA...
  10. pmc Immunohistological study of entheses in spondyloarthropathies: comparison in rheumatoid arthritis and osteoarthritis
    L Laloux
    Department of Rheumatology, , , , France
    Ann Rheum Dis 60:316-21. 2001
    ..These results suggest that CD8+ cells may have a key role in local inflammation in SpAs...
  11. ncbi request reprint Intra-articular injections of hylan G-F 20 in patients with symptomatic hip osteoarthritis: an open-label, multicentre, pilot study
    T Conrozier
    Department of Rheumatology, Centre Hospitalier Lyon Sud, Pierre Benite, France
    Clin Exp Rheumatol 21:605-10. 2003
    ..To obtain prospective data on feasibility and safety of intra-articular injections of hylan G-F20 in patients with symptomatic hip osteoarthritis (OA)...
  12. ncbi request reprint Patient knowledge of their disease: a French multicenter study in ankylosing spondylitis
    Pascal Claudepierre
    Department of Rheumatology, Hopital Henri Mondor, AP HP, Creteil, France
    Joint Bone Spine 71:550-6. 2004
    ..To assess knowledge of ankylosing spondylitis (AS) by patients and to identify factors associated with knowledge...
  13. ncbi request reprint Reliability, validity, and sensitivity to change of the Cochin hand functional disability scale in hand osteoarthritis
    S Poiraudeau
    The Réseau Rhumato Group, Paris, France
    Osteoarthritis Cartilage 9:570-7. 2001
    ..To assess the reliability, validity and sensitivity to change of the Cochin hand functional scale in hand osteoarthritis (OA)...
  14. ncbi request reprint Acute myeloid leukemia after infliximab: a case report
    F Kemta Lekpa
    Rheumatology Department, Henri Mondor Hospital, Paris XII University, Creteil, France
    Clin Exp Rheumatol 27:999-1000. 2009
    ..The evidence of a causal link remains unclear. We report a case of 60-year-old male patient who developed acute myeloid leukemia during infliximab therapy for ankylo-sing spondylitis...
  15. pmc Impaired redox status and cytochrome c oxidase deficiency in patients with polymyalgia rheumatica
    P Chariot
    Department of Pathology Neuromuscular Disorders, Hopital Henri Mondor, 94000 Creteil, France
    Ann Rheum Dis 60:1016-20. 2001
    ..To evaluate redox status and muscular mitochondrial abnormalities in patients with polymyalgia rheumatica (PMR)...
  16. ncbi request reprint Serum cartilage oligomeric matrix protein (COMP) level is a marker of disease activity in relapsing polychondritis
    F Kempta Lekpa
    Department of Rheumatology, Henri Mondor Hospital, University Paris 12, Creteil, France
    Clin Exp Rheumatol 28:553-5. 2010
    ..Until now, no reliable biomarker of disease activity in RP has been available. This study was designed to measure serum levels of cartilage biomarkers during both active and inactive phases of the disease...
  17. ncbi request reprint Intraarticular treatments for osteoarthritis: new perspectives
    Xavier Chevalier
    Department of Rheumatology, Hopital Henri Mondor, 94010 Creteil, France
    Curr Drug Targets 11:546-60. 2010
    ..Most importantly, the treatment strategy must be selected according to the pattern in an individual patient. Finally, with all intra-articular treatments, the risk/benefit ratio must be carefully evaluated...
  18. ncbi request reprint Estimation of the Bath Ankylosing Spondylitis Disease Activity Index cutoff for perceived symptom relief in patients with spondyloarthropathies
    Jean David Cohen
    Department of Rheumatology, Clinical Research Unit, and Spondylis, Henri Mondor Teaching Hospital, APHP, Creteil, France
    J Rheumatol 33:79-81. 2006
    ....
  19. ncbi request reprint Poorly and well controlled spondyloarthropathies: a comparison of 2 groups of patients
    Owonayo Oniankitan
    Department of Rheumatology and Spondylis, Henri Mondor Teaching Hospital, Creteil, France
    J Rheumatol 32:77-9. 2005
    ....
  20. ncbi request reprint Iliac vein thrombosis complicating SAPHO syndrome: MRI and histologic features of soft tissue lesions
    N Legoupil
    Department of Rheumatology, H pital Henri Mondor, , France
    Joint Bone Spine 68:79-83. 2001
    ..Lumbar MRI demonstrated a large tissue mass anterior to the involved vertebras and surrounding the right iliac vein. Histology of the mass showed aseptic inflammation...
  21. doi request reprint [Wells' cellulitis and bacterial necrotizing cellulitis induced by anakinra]
    M Livory
    Service de Dermatologie, Hopital Henri Mondor, 51, Avenue du Marechal de Lattre de Tassigny, 94010 Creteil Cedex, France
    Ann Dermatol Venereol 135:839-42. 2008
    ..It is used in the treatment of rheumatoid arthritis. The most frequent side effects are injection site reactions, which seem to have a toxic mechanism...
  22. doi request reprint Usefulness of taping in lower limb osteoarthritis. French clinical practice guidelines
    Pascal Richette
    Rheumatology Federation, Viggo Petersen Center, AP HP, Paris VII University, Lariboisière Teaching Hospital, Paris, France
    Joint Bone Spine 75:475-8. 2008
    ..To develop clinical practice guidelines about the use of taping in the management of lower limb osteoarthritis...
  23. doi request reprint [Evolution of the pharmacological management of osteoarthritis: the biologics]
    Xavier Chevalier
    Hopital Henri Mondor, Service de Rhumatologie, 94010 Creteil, France
    Presse Med 39:1164-71. 2010
    ..Intra-articular administration of biologics is hampered by their short resident time into the joint. Gene therapy is one of the possible way to prolong the local intra-articular delivery of biologics...
  24. ncbi request reprint Clinical response to intra-articular injections of hylan G-F 20 in symptomatic hip osteoarthritis: the OMERACT-OARSI criteria applied to the results of a pilot study
    Thierry Conrozier
    Department of Rheumatology, Centre Hospitalier Lyon Sud, 165, Chemin du Grand Revoyet, 69495 Pierre Benite Cedex, France
    Joint Bone Spine 73:705-9. 2006
    ..To assess, using the OMERACT-OARSI criteria, the clinical response of patients presenting with symptomatic hip osteoarthritis (OA) to one intra-articular injection of hylan G-F 20...
  25. ncbi request reprint Infliximab therapy for rheumatic diseases in patients with chronic hepatitis B or C
    Owonayo Oniankitan
    Department of Rheumatology, Henri Mondor Teaching Hospital, AP HP, Creteil, France
    J Rheumatol 31:107-9. 2004
    ..To describe the safety of tumor necrosis factor-a blockade in 2 patients with inflammatory rheumatic disease with chronic hepatitis B and C...
  26. ncbi request reprint Diagnostic value of 99mTc-HMDP bone scan in atypical osseous tuberculosis mimicking multiple secondary metastases
    Eva Evangelista
    Department of Nuclear Medicine, Henri Mondor Hospital, Assistance Publique Hopitaux de Paris, Paris XII University, Creteil, France
    Spine (Phila Pa 1976) 29:E85-7. 2004
    ..A case of atypical osseous tuberculosis (TB) mimicking multiple secondary metastases on radiologic and nuclear imaging is presented...
  27. doi request reprint The infrapatellar fat pad in knee osteoarthritis: an important source of interleukin-6 and its soluble receptor
    Emilie Distel
    INSERM UMR S 747, Universite Paris Descartes, Paris, France
    Arthritis Rheum 60:3374-7. 2009
    ....
  28. ncbi request reprint Infliximab to etanercept switch in patients with spondyloarthropathies and psoriatic arthritis: preliminary data
    Caroline Delaunay
    Department of Rheumatology, Henri Mondor Teaching Hospital, Creteil, France
    J Rheumatol 32:2183-5. 2005
    ..To report early experience of switching anti-tumor necrosis factor-a (TNF-alpha) therapy from infliximab to etanercept in patients with spondyloarthropathy (SpA) and psoriatic arthritis (PsA)...
  29. doi request reprint Effect of hyaluronic acid in symptomatic hip osteoarthritis: a multicenter, randomized, placebo-controlled trial
    Pascal Richette
    Hopital Lariboisiere, Assistance Publique Hopitaux de Paris, Paris, France
    Arthritis Rheum 60:824-30. 2009
    ..To evaluate the efficacy and tolerability of a single intraarticular (IA) injection of hyaluronic acid (HA) for the treatment of hip osteoarthritis (OA)...
  30. doi request reprint Premature enthusiasm for the use of methotrexate for refractory chondrocalcinosis: comment on the article by Chollet-Janin et al
    Thi Huyen Tran Doan
    Arthritis Rheum 58:2210-1. 2008
  31. ncbi request reprint Long-term experience with hylan GF-20 in the treatment of knee osteoarthritis
    Thierry Conrozier
    Service de Rhumatologie, Centre Hospitalier Lyon Sud, 165 Chemin du Grand Revoyet, 69495 Pierre Benite Cedex, France
    Expert Opin Pharmacother 9:1797-804. 2008
    ..Hylan GF-20 is a cross-linked hyaluronic acid derivative, FDA approved as a medical device since 1997 for the treatment of patients with symptomatic knee osteoarthritis...
  32. ncbi request reprint Biological markers for osteoarthritis: an update
    Xavier Chevalier
    Joint Bone Spine 72:106-9. 2005
  33. ncbi request reprint Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series
    Jean David Cohen
    General Hospital of Villeneuve, Saint George, France
    J Rheumatol 34:380-5. 2007
    ..To investigate anti-TNF-alpha induced psoriasis, we conducted a systematic analysis of the 6 cases we observed among our inflammatory patient cohort treated with anti-TNF-alpha (infliximab or etanercept)...
  34. doi request reprint Comparison of hylan and hyaluronic acid for knee osteoarthritis: comment on the article by Jüni et al
    Xavier Chevalier
    Arthritis Rheum 58:1560-1; author reply 1561-2. 2008
  35. ncbi request reprint Does structural worsening of osteoarthritis predict clinical worsening?
    Xavier Chevalier
    Joint Bone Spine 69:430-3. 2002
  36. pmc Is interleukin-1 a good target for therapeutic intervention in intervertebral disc degeneration: lessons from the osteoarthritic experience
    Philippe Goupille
    Arthritis Res Ther 9:110. 2007
    ..The clinical benefit of a local injection of IL-1ra in knee osteoarthritis may be limited by the antagonist's short half-life. Further studies with longer-lasting antagonists are needed to explore this new therapeutic approach...